Trials / Not Yet Recruiting
Not Yet RecruitingNCT06996106
Outcomes of PRF on Septoplasty in Patient With Nasal Septal Deviation
Effect of Platelet Rich Fibrin on Septoplasty :A Comparative Study
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Kafrelsheikh University · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to assess the effectiveness of Platelet-Rich Fibrin (PRF) in improving postoperative healing, reducing complications, and enhancing functional outcomes in patients undergoing septoplasty
Detailed description
Septoplasty is a routine surgical intervention to correct nasal septal deviation, a major cause of nasal obstruction and chronic sinusitis. Despite advancements, postoperative complications-such as mucosal injury, synechiae, septal perforation, and hematoma-continue to impact outcomes and patient satisfaction. Platelet-rich fibrin (PRF), first described by Choukroun et al., represents an autologous biomaterial rich in growth factors like PDGF, TGF-β, VEGF, and IGF-1, known to accelerate wound healing and tissue regeneration. Unlike platelet-rich plasma (PRP), PRF is easier to prepare, does not require anticoagulants, and forms a fibrin matrix conducive to sustained release of cytokines. Several studies across disciplines-oral surgery, dermatology, orthopedics-support the regenerative potential of PRF. In nasal surgery, the delicate mucosal environment could benefit significantly from enhanced healing facilitated by PRF.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Effect of Platelet Rich Fibrin on Septoplasty | it is a randomized trial of usage of platelet rich fibrin in septoplasty |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2026-01-01
- Completion
- 2026-02-01
- First posted
- 2025-05-30
- Last updated
- 2025-05-30
Source: ClinicalTrials.gov record NCT06996106. Inclusion in this directory is not an endorsement.